Cargando…
Survival According to Therapy Regimen for Small Intestinal Neuroendocrine Tumors
Introduction: Scarce data exist for therapy regimens other than somatostatin analogues (SSA) and peptide receptor radiotherapy (PRRT) for siNET. We analyzed real world data for differences in survival according to therapy. Patients and methods: Analysis of 145 patients, diagnosed between 1993 and 20...
Autores principales: | Koch, Christine, Bambey, Cornelia, Filmann, Natalie, Stanke, Marc, Waidmann, Oliver, Husmann, Gabriele, Bojunga, Joerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104547/ https://www.ncbi.nlm.nih.gov/pubmed/35566487 http://dx.doi.org/10.3390/jcm11092358 |
Ejemplares similares
-
Time from first tumor manifestation to diagnosis in patients with GEP-NET: Results from a large German tertiary referral center
por: Koch, Christine, et al.
Publicado: (2021) -
Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
por: Walter, Dirk, et al.
Publicado: (2018) -
Point Shear‐Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver‐Related Events in Patients With Chronic Viral Hepatitis
por: Hernandez Sampere, Lisa, et al.
Publicado: (2020) -
Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma
por: Koch, Christine, et al.
Publicado: (2019) -
Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
por: Levy, Sonja, et al.
Publicado: (2020)